Literature DB >> 25726384

Biliverdin reductase isozymes in metabolism.

Luke O'Brien1, Peter A Hosick2, Kezia John1, David E Stec3, Terry D Hinds4.   

Abstract

The biliverdin reductase (BVR) isozymes BVRA and BVRB are cell surface membrane receptors with pleiotropic functions. This review compares, for the first time, the structural and functional differences between the isozymes. They reduce biliverdin, a byproduct of heme catabolism, to bilirubin, display kinase activity, and BVRA, but not BVRB, can act as a transcription factor. The binding motifs present in the BVR isozymes allow a wide range of interactions with components of metabolically important signaling pathways such as the insulin receptor kinase cascades, protein kinases (PKs), and inflammatory mediators. In addition, serum bilirubin levels have been negatively associated with abdominal obesity and hypertriglyceridemia. We discuss the roles of the BVR isozymes in metabolism and their potential as therapeutic targets.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BVRA; BVRB; bilirubin; biliverdin reductase; diabetes; heme oxygenase; obesity

Mesh:

Substances:

Year:  2015        PMID: 25726384      PMCID: PMC4380527          DOI: 10.1016/j.tem.2015.02.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  76 in total

1.  Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.

Authors:  Rui Zeng; Ying Yao; Min Han; Xiaoqin Zhao; Xiao-Cheng Liu; Juncheng Wei; Yun Luo; Juan Zhang; Jianfeng Zhou; Shixuan Wang; Ding Ma; Gang Xu
Journal:  J Am Soc Nephrol       Date:  2008-01-09       Impact factor: 10.121

2.  The evaluation of relationship between adiponectin levels and epicardial adipose tissue thickness with low cardiac risk in Gilbert`s syndrome: an observational study.

Authors:  Erkan Cüre; Yüksel Ciçek; Medine Cumhur Cüre; Süleyman Yüce; Aynur Kırbaş; Arif Yılmaz
Journal:  Anadolu Kardiyol Derg       Date:  2013-10-25

3.  Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.

Authors:  Nicole Lerner-Marmarosh; Tihomir Miralem; Peter E M Gibbs; Mahin D Maines
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-07       Impact factor: 11.205

4.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

Authors:  D Jacobs; D Glossip; H Xing; A J Muslin; K Kornfeld
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

Review 5.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Authors:  Philippe Gual; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

Review 6.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.

Authors:  Wenge Li; Tin Oo Khor; Changjiang Xu; Guoxiang Shen; Woo-Sik Jeong; Siwang Yu; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2008-07-23       Impact factor: 5.858

7.  Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial.

Authors:  Charlotte Andersson; Peter Weeke; Emil Loldrup Fosbøl; Bente Brendorp; Lars Køber; Walmir Coutinho; Arya M Sharma; Luc Van Gaal; Nick Finer; W Philip T James; Ian D Caterson; Richard A Rode; Christian Torp-Pedersen
Journal:  Metabolism       Date:  2009-06-18       Impact factor: 8.694

8.  Confirmation of the assignment of human biliverdin reductase to chromosome 7.

Authors:  M Parkar; S J Jeremiah; S Povey; A F Lee; F O Finlay; P N Goodfellow; E Solomon
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

9.  Mapping of the newly identified biliverdin-IX beta reductase gene (BLVRB) to human chromosome 19q13.13-->q13.2 by fluorescence in situ hybridization.

Authors:  F Saito; T Yamaguchi; A Komuro; T Tobe; T Ikeuchi; M Tomita; H Nakajima
Journal:  Cytogenet Cell Genet       Date:  1995

10.  Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21.

Authors:  Terry D Hinds; Komal Sodhi; Charles Meadows; Larisa Fedorova; Nitin Puri; Dong Hyun Kim; Stephen J Peterson; Joseph Shapiro; Nader G Abraham; Attallah Kappas
Journal:  Obesity (Silver Spring)       Date:  2013-12-02       Impact factor: 5.002

View more
  49 in total

1.  Carnosic Acid Induces Anti-Inflammatory Effects in Paraquat-Treated SH-SY5Y Cells Through a Mechanism Involving a Crosstalk Between the Nrf2/HO-1 Axis and NF-κB.

Authors:  Marcos Roberto de Oliveira; Izabel Cristina Custódio de Souza; Cristina Ribas Fürstenau
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

Review 2.  HO-1 overexpression and underexpression: Clinical implications.

Authors:  George S Drummond; Jeffrey Baum; Menachem Greenberg; David Lewis; Nader G Abraham
Journal:  Arch Biochem Biophys       Date:  2019-08-16       Impact factor: 4.013

Review 3.  Bilirubin in the Liver-Gut Signaling Axis.

Authors:  Abdul-Rizaq Hamoud; Lauren Weaver; David E Stec; Terry D Hinds
Journal:  Trends Endocrinol Metab       Date:  2018-02-03       Impact factor: 12.015

4.  Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Authors:  Tihomir Miralem; Nicole Lerner-Marmarosh; Peter E M Gibbs; Jermaine L Jenkins; Chelsea Heimiller; Mahin D Maines
Journal:  FASEB J       Date:  2016-05-10       Impact factor: 5.191

5.  Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3β Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Terry D Hinds; Katherine A Burns; Peter A Hosick; Lucien McBeth; Andrea Nestor-Kalinoski; Heather A Drummond; Abdulhadi A AlAmodi; Michael W Hankins; John P Vanden Heuvel; David E Stec
Journal:  J Biol Chem       Date:  2016-10-10       Impact factor: 5.157

Review 6.  Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome.

Authors:  Nader G Abraham; Joshua M Junge; George S Drummond
Journal:  Trends Pharmacol Sci       Date:  2015-10-26       Impact factor: 14.819

7.  Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.

Authors:  Terry D Hinds; Peter A Hosick; Shujuan Chen; Robert H Tukey; Michael W Hankins; Andrea Nestor-Kalinoski; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-17       Impact factor: 4.310

8.  Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?

Authors:  Terry D Hinds; Samuel O Adeosun; Abdulhadi A Alamodi; David E Stec
Journal:  Med Hypotheses       Date:  2016-08-31       Impact factor: 1.538

Review 9.  Bilirubin, a Cardiometabolic Signaling Molecule.

Authors:  Terry D Hinds; David E Stec
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

10.  A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity.

Authors:  Samuel O Adeosun; Kyle H Moore; David M Lang; Assumpta C Nwaneri; Terry D Hinds; David E Stec
Journal:  React Oxyg Species (Apex)       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.